McPate, M. J., Duncan, R. S., Hancox, J. C., & Witchel, H. J. (2008). Pharmacology of the short QT syndrome N588K-hERG K(+) channel mutation: Differential impact on selected class I and class III antiarrhythmic drugs. Nature Publishing Group.
استشهاد بنمط شيكاغوMcPate, M J., R S. Duncan, J C. Hancox, و H J. Witchel. Pharmacology of the Short QT Syndrome N588K-hERG K(+) Channel Mutation: Differential Impact On Selected Class I and Class III Antiarrhythmic Drugs. Nature Publishing Group, 2008.
MLA استشهادMcPate, M J., R S. Duncan, J C. Hancox, و H J. Witchel. Pharmacology of the Short QT Syndrome N588K-hERG K(+) Channel Mutation: Differential Impact On Selected Class I and Class III Antiarrhythmic Drugs. Nature Publishing Group, 2008.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.